Global Information would like to present a new market research report, "Asia Pacific Markets for Interventional Cardiology Devices 2013" by Millennium Research Group.
The potential Chinese patient population for coronary stenting has historically been underpenetrated due to the high cost of the devices. Health care reforms in China supported rapid expansion of the Chinese drug-eluting stent market in 2009, and will continue to fuel growth in the coming years. "This amount of funding earmarked for a public health care system will vastly expand the volume of drug-eluting stent procedures performed in China," says Dan Whalen, Analyst at MRG. "With more people able to afford the procedure, this market is expected to grow an average of nearly 20% per year over the next five years, which presents a huge opportunity for new and emerging drug-eluting stent manufacturers in the region."